A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma
Clinical trial NCT07522476 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07522476
- Sponsor
- Virogin Biotech Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-01-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.